LOCALLY ADVANCED HEPATOCELLULAR CARCINOMA
Clinical trials for LOCALLY ADVANCED HEPATOCELLULAR CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED HEPATOCELLULAR CARCINOMA trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED HEPATOCELLULAR CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cancer trial tests 'Less is More' approach to powerful drug
Disease control Recruiting nowThis study is testing a new method for giving the cancer drug atezolizumab. Researchers want to see if they can use lower doses, given less often, by carefully monitoring drug levels in a patient's blood. The goal is to see if this personalized approach can still control the canc…
Matched conditions: LOCALLY ADVANCED HEPATOCELLULAR CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Custom-Made vaccine aims to train immune system to fight advanced cancers
Disease control Recruiting nowThis study is testing a new, personalized vaccine designed to target the unique proteins on a patient's own cancer cells. It is being given alongside an existing immunotherapy drug (pembrolizumab) to see if the combination is safe and can help control advanced solid tumors that h…
Matched conditions: LOCALLY ADVANCED HEPATOCELLULAR CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC
-
New Two-Pronged attack on tough liver cancer
Disease control Recruiting nowThis study is testing if a two-step treatment works better for controlling advanced liver cancer that is still confined to the liver. All patients first receive a targeted radiation treatment directly to the liver tumors. Then, half receive a combination of two immunotherapy drug…
Matched conditions: LOCALLY ADVANCED HEPATOCELLULAR CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Centre, Singapore • Aim: Disease control
Last updated Mar 20, 2026 14:47 UTC
-
New hope for liver cancer patients when first treatment stops working
Disease control Recruiting nowThis study is for people with advanced liver cancer that cannot be removed by surgery and has continued to grow despite their first treatment. Researchers want to see if continuing one of the original drugs (atezolizumab) alongside a new type of drug (cabozantinib or lenvatinib) …
Matched conditions: LOCALLY ADVANCED HEPATOCELLULAR CARCINOMA
Phase: PHASE2 • Sponsor: Academic and Community Cancer Research United • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC
-
Could a common drug help cancer patients regain lost weight?
Symptom relief Recruiting nowThis study is testing whether olanzapine, a medication that affects brain chemicals, can help cancer patients who are losing too much weight and have poor appetite. The trial will involve 66 adults with advanced cancers of the stomach, liver, pancreas, colon, or lung who have los…
Matched conditions: LOCALLY ADVANCED HEPATOCELLULAR CARCINOMA
Phase: PHASE2 • Sponsor: OHSU Knight Cancer Institute • Aim: Symptom relief
Last updated Apr 01, 2026 14:41 UTC